Nanomedicine Market Share, Price, Scope, Outlook, Report and Forecast Period Of 2022-2027
The new report by Expert Market Research titled, ‘Global Nanomedicine Market Price, Scope, Size, Share, Trends, Analysis, Report and Forecast 2022-2027’, gives an in-depth analysis of the global nanomedicine market, assessing the market based on its segments like product type, Application, Nanomolecule Type and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Request a free sample copy in PDF or view the report
The key highlights of the report include:
Market Overview (2017-2027)
Forecast CAGR (2022-2027): 11.6%
Forecast Market Size (2027): USD 391.5 billion
The rising usage of nanomaterials such as nanocapsules and nanotubes in drug delivery systems can be linked to the rise in demand for nanomedicines. The rise in cancer and cardiovascular disease occurrences has boosted the need for nanomedicines, resulting in increased public and private investment in nanomedicine research and breakthroughs in biodegradable nanoparticles.
The cost-effectiveness of these medicines, as well as their lack of adverse effects, are important drivers of the nanomedicine industry’s expansion.
The North American nanomedicine sector is predicted to be one of the main markets for nanomedicine in the forecast period of 2022-2027, thanks to significant government investment on nanomedicine research in the United States.
The region’s growth is attributed to the greater availability of patented nanomedicine items. Nanomedicine is easily available in this region, in addition to a well-developed healthcare infrastructure and a high prevalence of cancer, which has assisted market expansion.
The Asia Pacific region’s huge senior population is experiencing high rates of cancer and cardiovascular illness, which is likely to drive the region’s nanomedicine industry.
The regional market for nanomedicine is predicted to be one of the fastest expanding. Increased research funds to combat life-threatening diseases are likely to boost market expansion in the Asia Pacific, with nations like China and Japan leading the way.
Industry Definition and Major Segments
Nanomedicine is a branch of nanotechnology that focuses on diagnosing, treating, monitoring, and controlling biological systems. Modifying materials at the nanoscale, it increases drug delivery. As a result, nanomedicine has helped in the treatment of a wide range of diseases.
Nanomedicine is still in its infancy, with a slew of new products in the works. Nanobiotix has discovered 230 nanomedicine items that are either labeled or in the testing phase. Out of the 230 products, 49 are now on the market, and 122 are in various stages of clinical testing, including Phase II and Phase III trials.
By application, the market is categorized into:
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
Based on product type, the market can be segmented into:
- Regenerative Medicine
- In-Vitro Diagnostics
- In-Vivo Diagnostics
Based on nano molecule type, the industry is categorized into:
- Nanoparticles and Quantum Dots
- Metal and Metal Compounds
- Polymer and Polymer Drug Conjugate
- Hydrogel Nanoparticles
- Inorganic Nanoparticles
The major regional markets of nanomedicine are:
- North America
- The Asia Pacific
- Latin America
- The Middle East and Africa
Nanotechnology is now making great development in the identification and treatment of chronic diseases such as cancer, heart disease, and other disorders in the healthcare industry, which is one of the most important areas where nanotechnology has made substantial success.
As healthcare corporations focus on transdermal insulin administration and the industry’s attention shifts toward transdermal medicine delivery, businesses investigating patch technology have attracted considerable funding. Furthermore, in order to limit the danger of adverse effects, the personalized medicine delivery strategy is being heavily emphasized.
This approach delivers reachability with greater efficacy and less degradation by bypassing the body’s defense mechanisms. In the next years, such technological advancements and investments are projected to propel the industry forward.
Key Market Players
The major players in the market are Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Inc., Ablynx N.V., AMAG Pharmaceuticals, Inc., Celgene Corporation, and Others.
About Us :
Expert Market Research (EMR) is a leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium-scale enterprises.
EMR customizes syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate, and actionable industry intelligence so that they may formulate informed, effective, and intelligent business strategies and ensure their leadership in the market.
Media Contact :
Company Name: Claight Corporation
Contact Person: Louis Wane, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gloud Street, Sheridan, WY 82801, USA